NIPH Clinical Trials Search

Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Massive hemorrhage by trauma, gastrointestinal hemorrhage
Date of first enrollment	2014/01/10
Target sample size	70
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	Term:28 weeks infusion:Red cell concentrated 10units, ordinary blood transfusion concentrated fibrin preparation 3g Term:28 weeks infusion:Red cell concentrated 10units, ordinary blood transfusion

Outcome(s)

Primary Outcome	The amount of total blood tranfusion until hemostasis completion
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria
Exclude criteria	1.Pregnant woman 2.Under 20 years old 3.Immunocompromised (state) patients 4.Patients with allegy for blood products 5.Patients who are diagnosed as congenital low fibrinogen blood symptom 6.the patient that informed consent is not provided 7.the patient who is dead during primary care treatment even MTP procedure was exercised or not given the treatment with RCC,FFP and the concentrated fibrin preparation. 8.the patient who cannot perform a blood test after dosage